Talk:Ropinirole
 |
This article is in the 'Talk' namespace because it is an unfinished draft. This section is used to host drafts for unpublished articles as well as discussions for published ones. If you'd like to use this area to discuss this draft, please do so in the 'Discussion' section at the very bottom of the page. This notice will be removed once this draft has been approved for publication by an administrator. |
 |
This page has not been fully approved by the PsychonautWiki administrators. It may contain incorrect information, particularly with respect to dosage, duration, subjective effects, toxicity and other risks. It may also not meet PW style and grammar standards. |
| Summary sheet: Ropinirole |
Template:SubstanceBox/Ropinirole
Duration: 4 to 8 hours, drug onset within first hour
History and culture
Ropinirole, sold under the brand name Requip among others, is a medication used to treat Parkinson's disease. It was developed as a successor to pramipexole, with the aim of reducing side effects common to dopamine agonists. The FDA approved ropinirole for the treatment of Parkinson's disease in 1997, and it has been frequently prescribed off-label for the treatment of restless legs syndrome as well as extrapyrimidal symptoms, sexual dysfunction, and anhedonia associated with SSRI treatment.
Chemistry
 |
This chemistry section is incomplete. You can help by adding to it. |
Pharmacology
Ropinirole acts as a D2, D3, and D4 dopamine receptor agonist with highest affinity for D3. It is weakly active at 5-HT2 and α2 receptors, and is said to have virtually no affinity for 5-HT1, GABA, mAChR, α1, or β-adrenoreceptors.
Ropinirole is metabolized primarily by cytochrome P450 CYP1A2 to form two metabolites; SK&F-104557 and SK&F-89124, both of which are renally excreted, and at doses higher than clinical, is also metabolized by CYP3A4. At doses greater than 24 mg, CYP2D6 may be inhibited, although this has been tested only in vitro.
Subjective effects
Cognitive effects 
Experience reports
There are currently 0 experience reports which describe the effects of this substance in our experience index.
Additional experience reports can be found here:
Toxicity and harm potential
 |
This toxicity and harm potential section is a stub. As a result, it may contain incomplete or even dangerously wrong information! You can help by expanding upon or correcting it. |
It is strongly recommended that one use harm reduction practices when using this substance.
Lethal dosage
Tolerance and addiction potential
Dangerous interactions
| |
This dangerous interactions section is a stub. As such, it may contain incomplete or invalid information. You can help by expanding upon or correcting it. |
Warning: Many psychoactive substances that are reasonably safe to use on their own can suddenly become dangerous and even life-threatening when combined with certain other substances. The following list provides some known dangerous interactions (although it is not guaranteed to include all of them).
Always conduct independent research (e.g. Google, DuckDuckGo, PubMed) to ensure that a combination of two or more substances is safe to consume. Some of the listed interactions have been sourced from TripSit.
Legal status
 |
This legality section is a stub. As such, it may contain incomplete or wrong information. You can help by expanding it. |
See also
External links
(List along order below)
- SUBSTANCE (Wikipedia)
- SUBSTANCE (Erowid Vault)
- SUBSTANCE ([PiHKAL or TiHKAL] / Isomer Design)
Literature
- APA formatted reference
Please see the citation formatting guide if you need assistance properly formatting citations.